EMV Capital PLC (AIM: EMVC), the London-headquartered deep tech and life sciences venture capital investment group, has announced the appointment of Grant Thornton UK Advisory & Tax LLP as its new Nominated Adviser and Shore Capital Stockbrokers Limited as its new Broker, both with immediate effect from 9 November 2026. The changes replace the company's previous adviser and broker arrangements on AIM, where EMVC has been quoted since listing on the London Stock Exchange's growth market. For AIM-listed companies, maintaining a Nominated Adviser is a regulatory requirement, making the swift appointment of Grant Thornton significant for the company's continued compliance and market standing.

Key Points

  • EMV Capital PLC (EMVC) is a deep tech and life sciences VC investment group quoted on AIM
  • Grant Thornton UK Advisory & Tax LLP appointed as Nominated Adviser; Shore Capital Stockbrokers Limited appointed as Broker, both with immediate effect from 9 November 2026
  • No financial terms or advisory fees were disclosed in the announcement
  • Investors should watch for any subsequent strategic updates or portfolio announcements under the new adviser and broker relationship

Grant Thornton and Shore Capital Take Up EMVC Roles With Immediate Effect

The announcement confirms that Grant Thornton UK Advisory & Tax LLP, a well-established professional services firm, assumes the Nominated Adviser role for EMV Capital, while Shore Capital Stockbrokers Limited steps in as Broker. Both appointments carry immediate effect as of 9 November 2026. The company did not disclose any financial terms relating to these appointments in the announcement. Contacts named at Grant Thornton include Jamie Barklem, Harrison Clarke, Ciara Donnelly, and Elliot Peters, while Mark Percy and Fiona Conroy are listed as the Shore Capital contacts for EMV Capital.

EMV Capital's Evergreen VC Structure and Deep Tech Investment Focus

EMV Capital describes itself as a deep tech and life sciences venture capital investment group with an international portfolio of early-stage, IP-rich companies. The group's revenue model spans direct equity stakes, carried interest, fund management of the Evergreen EIS and Martlet Capital Funds, and syndicated investments through a third-party investor network. Headquartered in London with a Cambridge presence, the company targets capital-efficient investments in fast-growing sectors. Its proactive management style includes Board representation and a dedicated Value Creation Services practice aimed at advancing portfolio companies to key value inflection points.

AIM Rule 17 Disclosure: Dr Charles Spicer's Prior Directorship at MJ Hudson Group

Alongside the adviser changes, EMV Capital has published a director disclosure under AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies. The disclosure relates to non-executive director Dr Charles Spicer, who previously served on the board of MJ Hudson Group Plc, resigning on 19 December 2022. The announcement states that after his departure, MJ Hudson Group entered a Creditors' Winding Up on 11 August 2023 and remains in liquidation. The company has included this disclosure as part of its regulatory obligations connected to the change of Nominated Adviser.